Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies
出版年份 2023 全文链接
标题
Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies
作者
关键词
-
出版物
JOURNAL OF IMMUNOLOGY
Volume 211, Issue 10, Pages 1459-1467
出版商
The American Association of Immunologists
发表日期
2023-11-07
DOI
10.4049/jimmunol.2300315
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Molecular fate-mapping of serum antibody responses to repeat immunization
- (2023) Ariën Schiepers et al. NATURE
- Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine
- (2023) Jing Zou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Bivalent Boosters against Severe Omicron Infection
- (2023) Dan-Yu Lin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years
- (2023) Patricia Winokur et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
- (2023) Ai-ris Y. Collier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Response to Omicron BA.4–BA.5 Bivalent Booster
- (2023) Qian Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants
- (2023) Panke Qu et al. Cell Reports
- Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
- (2023) Geraldine Nouailles et al. Nature Microbiology
- Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
- (2023) Angela R. Branche et al. NATURE MEDICINE
- Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
- (2022) Katharina Röltgen et al. CELL
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
- (2022) Sandile Cele et al. NATURE
- SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
- (2022) Peter J. Halfmann et al. NATURE
- A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection
- (2022) Guillaume Beaudoin-Bussières et al. Cell Reports
- Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
- (2022) John P. Evans et al. Cell Host & Microbe
- Pan-coronavirus vaccine pipeline takes form
- (2022) Elie Dolgin NATURE REVIEWS DRUG DISCOVERY
- Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants
- (2022) John P. Evans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multimericity Amplifies the Synergy of BCR and TLR4 for B Cell Activation and Antibody Class Switching
- (2022) Egest J. Pone et al. Frontiers in Immunology
- Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
- (2022) Jasmin Quandt et al. Science Immunology
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
- (2022) Panke Qu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
- (2022) Alexander A. Cohen et al. SCIENCE
- Broadly neutralizing antibodies target the coronavirus fusion peptide
- (2022) Cherrelle Dacon et al. SCIENCE
- ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
- (2022) Jun Siong Low et al. SCIENCE
- Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters
- (2022) Shuofeng Yuan et al. SCIENCE
- A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
- (2022) Yang Liu et al. Nature Communications
- Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination
- (2022) Jinyi Tang et al. Science Immunology
- Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial
- (2022) Spyros Chalkias et al. NATURE MEDICINE
- Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice
- (2022) Suzanne M. Scheaffer et al. NATURE MEDICINE
- A Bivalent Omicron-Containing Booster Vaccine against Covid-19
- (2022) Spyros Chalkias et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
- (2022) Sebastian Havervall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants
- (2022) Panke Qu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
- (2022) Tianyang Mao et al. SCIENCE
- Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
- (2022) Young-Jun Park et al. SCIENCE
- SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
- (2022) Kaori Sano et al. Nature Communications
- Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark
- (2022) Frederik Plesner Lyngse et al. Nature Communications
- SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations
- (2022) Elizabeth M. Anderson et al. Cell Reports
- Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
- (2022) Panke Qu et al. Cell Host & Microbe
- Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation
- (2022) Markus Hoffmann et al. LANCET INFECTIOUS DISEASES
- Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
- (2022) Chaitanya Kurhade et al. NATURE MEDICINE
- Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster
- (2022) Meredith E. Davis-Gardner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
- (2021) Cyrielle Fougeroux et al. Nature Communications
- SARS-CoV-2 spike D614G change enhances replication and transmission
- (2021) Bin Zhou et al. NATURE
- Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
- (2021) Naveenchandra Suryadevara et al. CELL
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques
- (2021) Yongjun Sui et al. JCI Insight
- Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
- (2021) Irfan Ullah et al. IMMUNITY
- Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
- (2021) Rachel Yamin et al. NATURE
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection
- (2021) Stacey A. Lapp et al. PLoS One
- Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
- (2021) Hannah A. D. King et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy
- (2021) Ying Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Broad betacoronavirus neutralization by a stem helix–specific human antibody
- (2021) Dora Pinto et al. SCIENCE
- Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models
- (2021) Neeltje van Doremalen et al. Science Translational Medicine
- Immune imprinting and SARS-CoV-2 vaccine design
- (2021) Adam K. Wheatley et al. TRENDS IN IMMUNOLOGY
- Immunological imprinting of the antibody response in COVID-19 patients
- (2021) Teresa Aydillo et al. Nature Communications
- Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding
- (2021) Jakob Trimpert et al. Cell Reports
- Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
- (2021) Kanika Vanshylla et al. Cell Host & Microbe
- Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
- (2021) Dennis Lapuente et al. Nature Communications
- SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
- (2021) M. Gordon Joyce et al. Cell Reports
- Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)
- (2021) Jakob Trimpert et al. Science Advances
- Current and future nanoparticle vaccines for COVID-19
- (2021) Mai N. Vu et al. EBioMedicine
- Original Antigenic Sin: How Original? How Sinful?
- (2020) Jonathan W. Yewdell et al. Cold Spring Harbor Perspectives in Medicine
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
- (2020) Naoki Kaneko et al. CELL
- Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
- (2020) Amin Addetia et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Spike mutation D614G alters SARS-CoV-2 fitness
- (2020) Jessica A. Plante et al. NATURE
- A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone
- (2020) Baoshan Zhang et al. Scientific Reports
- Pathological changes in the lungs and lymphatic organs of twelve COVID-19 autopsy cases
- (2020) Qian Liu et al. National Science Review
- Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection
- (2020) Sang Heui Seo et al. Vaccines
- Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
- (2020) Alexandra Schäfer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Correlates of protection against SARS-CoV-2 in rhesus macaques
- (2020) Katherine McMahan et al. NATURE
- SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
- (2020) Lizhou Zhang et al. Nature Communications
- Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
- (2020) Michael W. Russell et al. Frontiers in Immunology
- Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift
- (2018) Meghan O. Altman et al. VIRAL IMMUNOLOGY
- Polyvalent vaccines: High-maintenance heroes
- (2018) Barbara Schlingmann et al. PLoS Pathogens
- Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation
- (2016) Rina F. Villar et al. Scientific Reports
- B cell antigen receptors of the IgM and IgD classes are clustered in different protein islands that are altered during B cell activation
- (2015) Palash Chandra Maity et al. Science Signaling
- B cell antigen receptors of the IgM and IgD classes are clustered in different protein islands that are altered during B cell activation
- (2015) Palash Chandra Maity et al. Science Signaling
- Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
- (2014) X.-C. Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B cell activation involves nanoscale receptor reorganizations and inside-out signaling by Syk
- (2014) Kathrin Kläsener et al. eLife
- GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution
- (2010) Sarah Costers et al. VIRUS RESEARCH
- Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus
- (2009) Kimberly A. Dowd et al. GASTROENTEROLOGY
- Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection
- (2009) Penny L. Moore et al. PLoS Pathogens
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started